Form 4/A for AYTU AYTU BIOPHARMA, INC
Accepted 2024-11-08 00:00:00 ET · period of report 2023-08-11 · accession 0000912282-24-000752 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-11-08 | 2023-08-11 | AYTU | LIU VIVIAN H | Dir | A - Grant | $0.00 | +1,500 | 8,325 | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-08-11 | A | A | 1,500 | $0.00 | 8,325 | D | — | — | (F1) Grant of restricted shares, which vest as follows: 1/3 on August 11, 2024, with the remaining restricted shares vesting in eight equal installments every three months beginning November 11, 2024. (F2) Reflects 1-for-20 reverse stock split effected by the Issuer on January 6, 2023. |